Online Technology Transfer

Feb. 7, 2002
Cambridge, Mass.

Cambridge, Mass. . . . ChromaDex Inc. and Bayer AG have completed a technology transfer agreement employing yet2.com, a global marketplace for the exchange of intellectual assets on the Internet. The terms of the agreement specify that Bayer AG will license its bioluminescence, thinlayer chromatography toxicity (BIO-TLC) technology to ChromaDex, a supplier of phytochemical reference standards and toxicity screening tools. ChromaDex and Bayer will jointly trademark products that ChromaDex develops using the Bayer BIO-TLC technology.

Sponsored Recommendations

Aug. 22, 2025
Discover how to meet growing customer demands for custom products without overextending your engineering team. Learn how scaling your automation strategy can help you win more...
Aug. 22, 2025
Join industry leaders to explore how cutting edge digital technologies are transforming factories. Learn how to boost throughput, enhance flexibility, and accelerate your digital...
Aug. 22, 2025
Explore the future of manufacturing. Learn how to leverage the latest digital technologies and strategies to build a more efficient, agile, and resilient digital factory.
Aug. 21, 2025
A look into the latest improvements in motion control through high-performance drives, AI enhancements, and faster communication protocols.

Voice your opinion!

To join the conversation, and become an exclusive member of Machine Design, create an account today!